annual CFO:
-$292.37M-$104.21M(-55.38%)Summary
- As of today (May 29, 2025), DYN annual cash flow from operations is -$292.37 million, with the most recent change of -$104.21 million (-55.38%) on December 31, 2024.
- During the last 3 years, DYN annual CFO has fallen by -$172.81 million (-144.53%).
- DYN annual CFO is now -6921.35% below its all-time high of -$4.16 million, reached on December 31, 2018.
Performance
DYN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$105.89M-$21.56M(-25.56%)Summary
- As of today (May 29, 2025), DYN quarterly cash flow from operations is -$105.89 million, with the most recent change of -$21.56 million (-25.56%) on March 31, 2025.
- Over the past year, DYN quarterly CFO has dropped by -$27.36 million (-34.83%).
- DYN quarterly CFO is now -1352.98% below its all-time high of -$7.29 million, reached on March 31, 2020.
Performance
DYN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$319.73M-$27.36M(-9.36%)Summary
- As of today (May 29, 2025), DYN TTM cash flow from operations is -$319.73 million, with the most recent change of -$27.36 million (-9.36%) on March 31, 2025.
- Over the past year, DYN TTM CFO has dropped by -$99.94 million (-45.47%).
- DYN TTM CFO is now -4287.01% below its all-time high of -$7.29 million, reached on March 31, 2020.
Performance
DYN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
DYN Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -55.4% | -34.8% | -45.5% |
| 3 y3 years | -144.5% | -108.7% | -110.5% |
| 5 y5 years | -2370.6% | -1353.0% | -4287.0% |
DYN Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -144.5% | at low | -262.8% | at low | -133.9% | at low |
| 5 y | 5-year | -2370.6% | at low | -1353.0% | at low | -4287.0% | at low |
| alltime | all time | -6921.4% | at low | -1353.0% | at low | -4287.0% | at low |
DYN Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$105.89M(+25.6%) | -$319.73M(+9.4%) |
| Dec 2024 | -$292.37M(+55.4%) | -$84.33M(+13.0%) | -$292.37M(+20.3%) |
| Sep 2024 | - | -$74.63M(+36.0%) | -$243.04M(+11.0%) |
| Jun 2024 | - | -$54.87M(-30.1%) | -$219.01M(-0.4%) |
| Mar 2024 | - | -$78.54M(+124.4%) | -$219.79M(+16.8%) |
| Dec 2023 | -$188.16M(+22.5%) | -$35.01M(-30.8%) | -$188.16M(+3.2%) |
| Sep 2023 | - | -$50.60M(-9.1%) | -$182.34M(+4.5%) |
| Jun 2023 | - | -$55.64M(+18.6%) | -$174.55M(+16.5%) |
| Mar 2023 | - | -$46.91M(+60.7%) | -$149.81M(-2.5%) |
| Dec 2022 | -$153.65M | -$29.19M(-31.8%) | -$153.65M(+0.7%) |
| Sep 2022 | - | -$42.80M(+38.5%) | -$152.52M(+11.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$30.91M(-39.1%) | -$136.67M(-10.0%) |
| Mar 2022 | - | -$50.74M(+80.8%) | -$151.91M(+27.1%) |
| Dec 2021 | -$119.56M(+157.1%) | -$28.07M(+4.1%) | -$119.56M(+7.2%) |
| Sep 2021 | - | -$26.95M(-41.6%) | -$111.53M(+15.6%) |
| Jun 2021 | - | -$46.15M(+150.9%) | -$96.47M(+67.4%) |
| Mar 2021 | - | -$18.39M(-8.2%) | -$57.61M(+23.9%) |
| Dec 2020 | -$46.51M(+293.0%) | -$20.04M(+68.6%) | -$46.51M(+75.7%) |
| Sep 2020 | - | -$11.89M(+62.9%) | -$26.47M(+81.5%) |
| Jun 2020 | - | -$7.30M(+0.1%) | -$14.59M(+100.1%) |
| Mar 2020 | - | -$7.29M | -$7.29M |
| Dec 2019 | -$11.83M(+184.2%) | - | - |
| Dec 2018 | -$4.16M | - | - |
FAQ
- What is Dyne Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Dyne Therapeutics?
- What is Dyne Therapeutics annual CFO year-on-year change?
- What is Dyne Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly CFO year-on-year change?
- What is Dyne Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Dyne Therapeutics?
- What is Dyne Therapeutics TTM CFO year-on-year change?
What is Dyne Therapeutics annual cash flow from operations?
The current annual CFO of DYN is -$292.37M
What is the all time high annual CFO for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash flow from operations is -$4.16M
What is Dyne Therapeutics annual CFO year-on-year change?
Over the past year, DYN annual cash flow from operations has changed by -$104.21M (-55.38%)
What is Dyne Therapeutics quarterly cash flow from operations?
The current quarterly CFO of DYN is -$105.89M
What is the all time high quarterly CFO for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash flow from operations is -$7.29M
What is Dyne Therapeutics quarterly CFO year-on-year change?
Over the past year, DYN quarterly cash flow from operations has changed by -$27.36M (-34.83%)
What is Dyne Therapeutics TTM cash flow from operations?
The current TTM CFO of DYN is -$319.73M
What is the all time high TTM CFO for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM cash flow from operations is -$7.29M
What is Dyne Therapeutics TTM CFO year-on-year change?
Over the past year, DYN TTM cash flow from operations has changed by -$99.94M (-45.47%)